Pro-Dex Inc
$ 47.61
-0.92%
05 Mar - close price
- Market Cap 156,739,000 USD
- Current Price $ 47.61
- High / Low $ 47.61 / 45.65
- Stock P/E 14.09
- Book Value 12.97
- EPS 3.41
- Next Earning Report 2026-04-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.12 %
- ROE 0.31 %
- 52 Week High 70.26
- 52 Week Low 23.47
About
Pro-Dex, Inc. designs, develops and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company is headquartered in Irvine, California.
Analyst Target Price
$56.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-29 | 2025-10-30 | 2025-09-04 | 2025-05-01 | 2025-01-30 | 2024-10-31 | 2024-09-05 | 2024-05-02 | 2024-02-08 | 2023-11-02 | 2023-09-29 | 2023-05-04 |
| Reported EPS | 0.6619 | 1.4 | 0.36 | 0.85 | 0.61 | 0.75 | 0.46 | 0.19 | 0.14 | -0.17 | 0.42 | 0.36 |
| Estimated EPS | 0.59 | 0.5 | 0.47 | 0.47 | 0.38 | 0.29 | 0.35 | 0.35 | 0.35 | 0.32 | 0.33 | 0.26 |
| Surprise | 0.0719 | 0.9 | -0.11 | 0.38 | 0.23 | 0.46 | 0.11 | -0.16 | -0.21 | -0.49 | 0.09 | 0.1 |
| Surprise Percentage | 12.1864% | 180% | -23.4043% | 80.8511% | 60.5263% | 158.6207% | 31.4286% | -45.7143% | -60% | -153.125% | 27.2727% | 38.4615% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-30 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.62 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PDEX
2026-02-14 09:27:26
Pro-Dex (NASDAQ:PDEX) recently saw its share price cross above its 200-day moving average, trading at $39.48. Despite this technical milestone, the stock remains below its 50-day moving average, indicating mixed short-term and long-term signals. Analysts currently rate PDEX as a "Moderate Buy" with a $56.00 average price target, supported by strong Q4 earnings where the company beat estimates.
2026-02-14 07:27:55
Pro-Dex (PDEX) has completed its acquisition of Advanced Precision Machining LLC (APM) for approximately $8.65 million, making APM a wholly owned subsidiary. The acquisition of this long-standing supplier is expected to support Pro-Dex's expansion plans, contribute to future revenue growth, and streamline manufacturing processes. Analysts currently rate PDEX as a Buy with a $44.00 price target.
2026-02-12 21:57:39
Pro-Dex (PDEX) has completed the acquisition of Advanced Precision Machining LLC for approximately $8.65 million, integrating a key supplier that already produces components for Pro-Dex. The acquisition, largely funded by a $6.65 million term loan, is expected to streamline manufacturing, support expansion related to a major customer contract, and contribute to future revenue growth, while APM will continue its aerospace, defense, and U.S. Government contracting business independently. Spark, TipRanks' AI Analyst, rates PDEX as Neutral, citing solid profitability and improving leverage, though noting volatile cash flow and muted technical momentum.
2026-02-07 09:27:32
Pro-Dex (NASDAQ:PDEX) stock recently crossed above its 200-day moving average, signaling a potential bullish trend. The medical instruments supplier reported strong Q4 results, surpassing earnings and revenue estimates, and maintains healthy profitability with low leverage. Analysts have a "Moderate Buy" consensus rating with a $56.00 price target, while institutional investors have shown increased interest in the company.
2026-02-07 09:27:32
Pro-Dex (NASDAQ:PDEX) recently saw its shares cross above their 200-day moving average. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, alongside healthy net margins and return on equity. Analysts currently rate the stock as a "Moderate Buy" with a consensus target price of $56.00, and institutional ownership stands at approximately 15%.
2026-02-06 04:53:00
Pro-Dex (PDEX) reported Q2 2026 revenue of US$18.7 million and Basic EPS of US$0.67, with trailing twelve-month revenue at US$72.1 million and Basic EPS at US$3.48. Despite 68% trailing earnings growth, these figures were significantly boosted by a US$4.7 million one-off gain, raising questions about the durability of the recent profit increase. The company's P/E ratio of 11.1x is below industry averages, and its DCF fair value is estimated at US$61.92, suggesting potential undervaluation.
